切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2022, Vol. 11 ›› Issue (01) : 9 -12. doi: 10.3877/cma.j.issn.2095-3232.2022.01.003

专家论坛

原发免疫性血小板减少症脾切除术疗效评估和预测指标
王雅宁1, 李惜惜1, 解英俊1,()   
  1. 1. 130041 长春,吉林大学第二医院肝胆胰外科
  • 收稿日期:2021-11-11 出版日期:2022-02-10
  • 通信作者: 解英俊
  • 基金资助:
    吉林省卫生与健康技术创新项目(2018J053); 吉林省医疗卫生人才专项(2019SCZT015)

Assessment of therapeutic effect of splenectomy for primary immune thrombocytopenia and its predictor

Yaning Wang1, Xixi Li1, Yingjun Xie1()   

  • Received:2021-11-11 Published:2022-02-10
  • Corresponding author: Yingjun Xie
引用本文:

王雅宁, 李惜惜, 解英俊. 原发免疫性血小板减少症脾切除术疗效评估和预测指标[J]. 中华肝脏外科手术学电子杂志, 2022, 11(01): 9-12.

Yaning Wang, Xixi Li, Yingjun Xie. Assessment of therapeutic effect of splenectomy for primary immune thrombocytopenia and its predictor[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(01): 9-12.

[1]
中华医学会血液学分会血栓与止血学组. 成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)[J]. 中华血液学杂志, 2020, 41(8):617-623.
[2]
Cooper N, Ghanima W.Immune thrombocytopenia[J].N Engl J Med,2019,381(10):945-955.
[3]
Cole TJ.Glucocorticoid action and the development of selective glucocorticoid receptor ligands[J].Biotechnol Annu Rev,2006(12):269-300.
[4]
Vianelli N, Palandri F, Polverelli N,et al.Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years[J].Haematologica,2013,98(6):875-880.
[5]
Zheng D, Huang CS, Huang SB,et al.Laparoscopic splenectomy for primary immune thrombocytopenia: current status and challenges[J].World J Gastrointest Endosc,2016,8(17):610-615.
[6]
Palandri F, Catani L, Auteri G,et al.Understanding how older age drives decision-making and outcome in immune thrombocytopenia. a single centre study on 465 adult patients[J].Br J Haematol,2019,184(3):424-430.
[7]
Fabris F, Tassan T, Ramon R,et al.Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura[J].Br J Haematol,2001,112(3):637-640.
[8]
Navez J, Hubert C, Gigot JF,et al.Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura?[J].Platelets,2015,26(6):573-576.
[9]
Nyilas á, Paszt A, Borda B,et al.Predictive factors for success of laparoscopic splenectomy for ITP[J].JSLS,2018,22(4):e2018.00021.
[10]
Xu T, Li N, Jin F,et al.Predictive factors of idiopathic thrombocytopenic purpura and long-term survival in Chinese adults undergoing laparoscopic splenectomy[J].Surg Laparosc Endosc Percutan Tech,2016,26(5):397-400.
[11]
Kwiatkowska A, Radkowiak D, Wysocki M,et al.Prognostic factors for immune thrombocytopenic purpura remission after laparoscopic splenectomy: a cohort study[J].Medicina,2019,55(4):112.
[12]
Avila ML, Amiri N, Pullenayegum E,et al.Long-term outcomes after splenectomy in children with immune thrombocytopenia: an update on the registry data from the Intercontinental Cooperative ITP Study Group[J].Haematologica,2020,105(11):2682-2685.
[13]
British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy[J]. Br J Haematol, 2003, 120(4):574-596.
[14]
Neunert C, Lim W, Crowther M,et al.The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J].Blood,2011,117(16):4190-4207.
[15]
Rijcken E, Mees ST, Bisping G,et al.Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): a retrospective cohort study on longtime response predicting factors based on consensus criteria[J].Int J Surg,2014,12(12):1428-1433.
[16]
Liu EH, Dilip CK, Yeh TS,et al.Long-term relapse-free rurvival rate and predictive factors of idiopathic thrombocytopenic purpura in adults undergoing splenectomy[J].Biomed J,2013,36(1):23-27.
[17]
Liao R, Tang PY, Song JF,et al.Platelet count on preoperative day 1 predicts the long-term responses to laparoscopic splenectomy for Chinese patients with medically refractory idiopathic thrombocytopenic purpura[J].BMC Surg,2018,18(1):108.
[18]
Pang SJ, Lazarus AH.Mechanisms of platelet recovery in ITP associated with therapy[J].Ann Hematol,2010,89Suppl 1:31-35.
[19]
Najean Y, Rain JD, Billotey C.The site of destruction of autologous111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies[J].Br J Haematol,1997,97(3):547-550.
[20]
Sarpatwari A, Provan D, Erqou S,et al.Autologous111In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry[J].Br J Haematol,2010,151(5):477-487.
[21]
Amini SN, Nelson VS, Sobels A,et al.Autologous platelet scintigraphy and clinical outcome of splenectomy in immune thrombocytopenia: a systematic review and meta-analysis[J].Crit Rev Oncol Hematol,2020(153):103040.
[22]
Zheng CX, Ji ZQ, Zhang LJ,et al.Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia[J].J Transl Med,2012(10):208.
[23]
Furudoï A, Rivière é, Lazaro E,et al.Adult primary immune thrombocytopenia: spleen histology findings and outcomes according to rituximab use based on analysis of 41 cases[J].Am J Surg Pathol,2018,42(3):401-412.
[24]
胡志平,王东,朱继业. 脾切除术在自身免疫性血液系统疾病治疗中的价值 [J/OL]. 中华肝脏外科手术学电子杂志, 2019, 8(5):400-404.
[25]
Tastaldi L, Krpata DM, Prabhu AS,et al.Laparoscopic splenectomy for immune thrombocytopenia (ITP): long-term outcomes of a modern cohort[J].Surg Endosc,2019,33(2):475-485.
[1] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[2] 张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[3] 王宏宇. 固定与活动平台假体在全膝关节置换术中的应用价值[J]. 中华关节外科杂志(电子版), 2023, 17(06): 871-876.
[4] 李圣鹏, 方爱蓝, 刘诗宁, 王丹, 刘湘奇. 下颌阻生第三磨牙拔除难度的预测因素与评估方法[J]. 中华口腔医学研究杂志(电子版), 2023, 17(06): 441-445.
[5] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[6] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[7] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[8] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[9] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[10] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[11] 邢晓伟, 刘雨辰, 赵冰, 王明刚. 基于术前腹部CT的卷积神经网络对腹壁切口疝术后复发预测价值[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 677-681.
[12] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要